HighVista Strategies
Latest statistics and disclosures from HighVista Strategies's latest quarterly 13F-HR filing:
- Top 5 stock holdings are DBC, APGE, SYRE, MRUS, MSFT, and represent 20.47% of HighVista Strategies's stock portfolio.
- Added to shares of these 10 stocks: APGE (+$7.9M), SYRE (+$5.9M), ANSS, HES, JNPR, Sp Plus, CERE, GDX, KROS, SWTX.
- Started 50 new stock positions in KALV, CART, TSVT, PTGX, ROIV, CABA, HES, ABVX, VTRS, TDW.
- Reduced shares in these 10 stocks: , VMware (-$5.6M), IMVT, Horizon Therapeutics, stock, Seagen, , Cymabay Therapeutics, , Ambrx Biopharma.
- Sold out of its positions in ACAD, Activision Blizzard, ADBE, AKRO, Ambrx Biopharma, AMLX, ELV, ALV, CZR, CLDX.
- HighVista Strategies was a net buyer of stock by $46M.
- HighVista Strategies has $280M in assets under management (AUM), dropping by 29.79%.
- Central Index Key (CIK): 0001335325
Tip: Access up to 7 years of quarterly data
Positions held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for HighVista Strategies
HighVista Strategies holds 131 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Invesco Db Commdy Indx Trck Unit (DBC) | 11.8 | $33M | 1.4M | 22.97 |
|
|
| Apogee Therapeutics (APGE) | 2.8 | $7.9M | NEW | 119k | 66.45 |
|
| Spyre Therapeutics Com New (SYRE) | 2.1 | $5.9M | NEW | 154k | 37.93 |
|
| Merus N V (MRUS) | 2.0 | $5.5M | 122k | 45.03 |
|
|
| Microsoft Corporation (MSFT) | 1.8 | $5.2M | +23% | 12k | 420.72 |
|
| Arcellx Common Stock (ACLX) | 1.8 | $5.0M | -7% | 72k | 69.55 |
|
| Xpo Logistics Inc equity (XPO) | 1.7 | $4.7M | +46% | 38k | 122.03 |
|
| Nuvalent Inc-a (NUVL) | 1.6 | $4.5M | +10% | 60k | 75.09 |
|
| Ansys (ANSS) | 1.6 | $4.4M | NEW | 13k | 347.16 |
|
| Hess (HES) | 1.6 | $4.4M | NEW | 29k | 152.64 |
|
| Ideaya Biosciences (IDYA) | 1.6 | $4.4M | -21% | 99k | 43.88 |
|
| Juniper Networks (JNPR) | 1.5 | $4.3M | NEW | 115k | 37.06 |
|
| Sp Plus | 1.5 | $4.1M | NEW | 79k | 52.22 |
|
| Cerevel Therapeutics Hldng I (CERE) | 1.5 | $4.1M | +290% | 97k | 42.27 |
|
| Albertsons Cos Common Stock (ACI) | 1.4 | $4.0M | 189k | 21.44 |
|
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.4 | $3.9M | +71% | 158k | 24.90 |
|
| Axsome Therapeutics (AXSM) | 1.4 | $3.9M | -14% | 49k | 79.80 |
|
| Indivior Ord (INDV) | 1.4 | $3.8M | +37% | 179k | 21.38 |
|
| salesforce (CRM) | 1.4 | $3.8M | +20% | 13k | 301.18 |
|
| Amazon (AMZN) | 1.3 | $3.6M | +214% | 20k | 180.38 |
|
| Amedisys (AMED) | 1.3 | $3.6M | 39k | 92.16 |
|
|
| Capri Holdings SHS (CPRI) | 1.3 | $3.5M | 78k | 45.30 |
|
|
| Miragen Therapeutics (VRDN) | 1.2 | $3.5M | +89% | 199k | 17.51 |
|
| Insmed Com Par $.01 (INSM) | 1.2 | $3.4M | +58% | 127k | 27.13 |
|
| Xenon Pharmaceuticals (XENE) | 1.1 | $3.1M | +106% | 73k | 43.05 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.1 | $3.0M | 60k | 50.23 |
|
|
| Raytheon Technologies Corp (RTX) | 1.1 | $3.0M | +274% | 30k | 97.53 |
|
| Xoma Corp Del Com New (XOMA) | 1.0 | $2.9M | 119k | 24.05 |
|
|
| Olema Pharmaceuticals (OLMA) | 1.0 | $2.8M | 248k | 11.32 |
|
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 1.0 | $2.8M | NEW | 88k | 31.62 |
|
| Booking Holdings (BKNG) | 1.0 | $2.7M | +112% | 757.00 | 3627.88 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.9 | $2.7M | +532% | 6.7k | 393.72 |
|
| Keros Therapeutics (KROS) | 0.9 | $2.6M | NEW | 39k | 66.20 |
|
| Springworks Therapeutics (SWTX) | 0.9 | $2.5M | NEW | 51k | 49.22 |
|
| Visa Com Cl A (V) | 0.9 | $2.5M | +2% | 8.9k | 279.08 |
|
| Orthofix Medical (OFIX) | 0.9 | $2.4M | NEW | 168k | 14.52 |
|
| WESCO International (WCC) | 0.9 | $2.4M | +105% | 14k | 171.28 |
|
| Laureate Education Common Stock (LAUR) | 0.8 | $2.4M | +140% | 164k | 14.57 |
|
| Maplebear (CART) | 0.8 | $2.3M | NEW | 62k | 37.29 |
|
| Mrc Global Inc cmn (MRC) | 0.8 | $2.3M | NEW | 180k | 12.57 |
|
| Immunocore Hldgs Ads (IMCR) | 0.8 | $2.3M | -12% | 35k | 65.00 |
|
| Roivant Sciences SHS (ROIV) | 0.8 | $2.2M | NEW | 212k | 10.54 |
|
| Enliven Therapeutics (ELVN) | 0.8 | $2.2M | 127k | 17.59 |
|
|
| Meta Platforms Cl A (META) | 0.8 | $2.2M | +7% | 4.5k | 485.58 |
|
| Arvinas Ord (ARVN) | 0.8 | $2.1M | NEW | 51k | 41.28 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.7 | $2.0M | -17% | 36k | 56.09 |
|
| Fiserv (FI) | 0.7 | $2.0M | +15% | 13k | 159.82 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.7 | $1.9M | +17% | 156k | 12.41 |
|
| Intuit (INTU) | 0.7 | $1.9M | +36% | 3.0k | 650.00 |
|
| Lithia Motors (LAD) | 0.7 | $1.9M | +72% | 6.4k | 300.86 |
|
| Cogent Biosciences (COGT) | 0.7 | $1.9M | +41% | 281k | 6.72 |
|
| Alphabet Cap Stk Cl C (GOOG) | 0.7 | $1.9M | -25% | 12k | 152.26 |
|
| General Electric Com New (GE) | 0.6 | $1.8M | +27% | 13k | 140.09 |
|
| Kiniksa Pharmaceuticals Com Cl A | 0.6 | $1.7M | NEW | 89k | 19.73 |
|
| Bridgebio Pharma (BBIO) | 0.6 | $1.7M | +26% | 57k | 30.92 |
|
| Jd.com Spon Adr Cl A (JD) | 0.6 | $1.7M | +80% | 63k | 27.39 |
|
| Travere Therapeutics (TVTX) | 0.6 | $1.7M | +79% | 219k | 7.71 |
|
| Intra Cellular Therapies (ITCI) | 0.6 | $1.7M | +154% | 24k | 69.20 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.6 | $1.7M | NEW | 261k | 6.38 |
|
| Verizon Communications (VZ) | 0.6 | $1.6M | NEW | 39k | 41.96 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $1.6M | -49% | 37k | 42.86 |
|
| Micron Technology (MU) | 0.6 | $1.6M | -52% | 13k | 117.89 |
|
| Metropcs Communications (TMUS) | 0.6 | $1.6M | NEW | 9.5k | 163.22 |
|
| Transocean Registered Shs (RIG) | 0.6 | $1.5M | +55% | 246k | 6.28 |
|
| Pennymac Financial Services (PFSI) | 0.5 | $1.5M | 16k | 91.09 |
|
|
| Tidewater (TDW) | 0.5 | $1.4M | NEW | 15k | 92.00 |
|
| Ptc (PTC) | 0.5 | $1.4M | +4% | 7.4k | 188.94 |
|
| Camden Ppty Tr Sh Ben Int (CPT) | 0.5 | $1.4M | +143% | 14k | 98.40 |
|
| Philip Morris International (PM) | 0.5 | $1.4M | NEW | 15k | 91.62 |
|
| Equity Residential Sh Ben Int (EQR) | 0.5 | $1.4M | NEW | 22k | 63.11 |
|
| TransDigm Group Incorporated (TDG) | 0.5 | $1.4M | NEW | 1.1k | 1231.60 |
|
| Western Digital (WDC) | 0.5 | $1.4M | 20k | 68.24 |
|
|
| Mastercard Incorporated Cl A (MA) | 0.4 | $1.2M | -32% | 2.5k | 481.57 |
|
| Viatris (VTRS) | 0.4 | $1.2M | NEW | 103k | 11.94 |
|
| Tourmaline Bio (TRML) | 0.4 | $1.2M | NEW | 53k | 22.90 |
|
| Advanced Micro Devices (AMD) | 0.4 | $1.2M | NEW | 6.7k | 180.49 |
|
| Nu Hldgs Ord Shs Cl A (NU) | 0.4 | $1.2M | NEW | 101k | 11.93 |
|
| Constellation Brands Cl A (STZ) | 0.4 | $1.2M | NEW | 4.4k | 271.76 |
|
| Seagate Technology Hldngs Pl Ord Shs (STX) | 0.4 | $1.2M | NEW | 13k | 93.05 |
|
| Crowdstrike Hldgs Cl A (CRWD) | 0.4 | $1.2M | NEW | 3.7k | 320.59 |
|
| Stoneco Com Cl A (STNE) | 0.4 | $1.2M | +30% | 70k | 16.61 |
|
| Banco Bradesco S A Sp Adr Pfd New (BBD) | 0.4 | $1.1M | NEW | 400k | 2.86 |
|
| Hdfc Bank Sponsored Ads (HDB) | 0.4 | $1.1M | +116% | 20k | 55.97 |
|
| Take-Two Interactive Software (TTWO) | 0.4 | $1.1M | NEW | 7.6k | 148.49 |
|
| Icici Bank Adr (IBN) | 0.4 | $1.1M | +67% | 42k | 26.41 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.4 | $1.1M | +122% | 16k | 72.36 |
|
| Thermo Fisher Scientific (TMO) | 0.4 | $1.1M | NEW | 1.9k | 581.21 |
|
| Duolingo Cl A Com (DUOL) | 0.4 | $1.1M | NEW | 5.0k | 220.58 |
|
| Wal-Mart Stores (WMT) | 0.4 | $1.1M | NEW | 18k | 60.17 |
|
| First Ctzns Bancshares Inc N Cl A (FCNCA) | 0.4 | $1.1M | -31% | 661.00 | 1635.00 |
|
| Sea Sponsord Ads (SE) | 0.4 | $1.1M | +29% | 20k | 53.71 |
|
| Palo Alto Networks (PANW) | 0.4 | $1.1M | +36% | 3.7k | 284.13 |
|
| Bright Horizons Fam Sol In D (BFAM) | 0.4 | $1.0M | NEW | 9.2k | 113.36 |
|
| H World Group Sponsored Ads (HTHT) | 0.4 | $1.0M | +44% | 26k | 38.70 |
|
| Coinbase Global Com Cl A (COIN) | 0.4 | $997k | NEW | 3.8k | 265.12 |
|
| Bilibili Spons Ads Rep Z (BILI) | 0.4 | $984k | +66% | 88k | 11.20 |
|
| Terns Pharmaceuticals (TERN) | 0.3 | $972k | 148k | 6.56 |
|
|
| CRH Ord (CRH) | 0.3 | $966k | NEW | 11k | 86.26 |
|
| Alpine Immune Sciences | 0.3 | $903k | -42% | 23k | 39.64 |
|
| Pdd Holdings Sponsored Ads (PDD) | 0.3 | $844k | +99% | 7.3k | 116.25 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.3 | $826k | NEW | 58k | 14.30 |
|
| Geron Corporation (GERN) | 0.3 | $793k | +19% | 240k | 3.30 |
|
| Repare Therapeutics Ord (RPTX) | 0.3 | $778k | 165k | 4.71 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 0.3 | $744k | NEW | 16k | 46.81 |
|
| Immuneering Corp Class A Com (IMRX) | 0.3 | $736k | 255k | 2.89 |
|
|
| Krystal Biotech (KRYS) | 0.2 | $698k | -10% | 3.9k | 177.93 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.2 | $684k | -23% | 4.5k | 151.17 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $677k | -16% | 2.5k | 267.04 |
|
| Vaxcyte (PCVX) | 0.2 | $637k | -17% | 9.3k | 68.31 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.2 | $622k | NEW | 14k | 43.33 |
|
| Protagonist Therapeutics (PTGX) | 0.2 | $614k | NEW | 21k | 28.93 |
|
| Ke Hldgs Sponsored Ads (BEKE) | 0.2 | $588k | +82% | 43k | 13.73 |
|
| Baidu Spon Adr Rep A (BIDU) | 0.2 | $578k | 5.5k | 105.28 |
|
|
| Trip Com Group Ads (TCOM) | 0.2 | $554k | -37% | 13k | 43.89 |
|
| Mersana Therapeutics (MRSN) | 0.2 | $548k | NEW | 122k | 4.48 |
|
| Verona Pharma Sponsored Ads (VRNA) | 0.2 | $522k | +8% | 32k | 16.09 |
|
| Syndax Pharmaceuticals (SNDX) | 0.2 | $512k | -27% | 22k | 23.80 |
|
| Mirum Pharmaceuticals (MIRM) | 0.2 | $508k | NEW | 20k | 25.12 |
|
| Pliant Therapeutics (PLRX) | 0.2 | $507k | +10% | 34k | 14.90 |
|
| 2seventy Bio Common Stock (TSVT) | 0.2 | $500k | NEW | 94k | 5.35 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.2 | $495k | -53% | 16k | 31.86 |
|
| Revolution Medicines (RVMD) | 0.2 | $462k | -20% | 14k | 32.23 |
|
| Soleno Therapeutics (SLNO) | 0.2 | $446k | NEW | 10k | 42.80 |
|
| Apellis Pharmaceuticals (APLS) | 0.2 | $427k | NEW | 7.3k | 58.78 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 0.1 | $408k | -26% | 4.7k | 86.82 |
|
| Li Auto Sponsored Ads (LI) | 0.1 | $396k | +45% | 13k | 30.28 |
|
| Pharvaris N V (PHVS) | 0.1 | $387k | NEW | 17k | 23.11 |
|
| Tal Education Group Sponsored Ads (TAL) | 0.1 | $384k | -32% | 34k | 11.35 |
|
| Cabaletta Bio (CABA) | 0.1 | $379k | NEW | 22k | 17.06 |
|
| Kalvista Pharmaceuticals (KALV) | 0.1 | $378k | NEW | 32k | 11.86 |
|
| Couchbase (BASE) | 0.1 | $362k | NEW | 14k | 26.31 |
|
Past Filings by HighVista Strategies
SEC 13F filings are viewable for HighVista Strategies going back to 2010
- HighVista Strategies 2024 Q1 filed May 15, 2024
- HighVista Strategies 2023 Q3 filed Nov. 14, 2023
- HighVista Strategies 2023 Q2 filed Aug. 14, 2023
- HighVista Strategies 2023 Q1 filed May 15, 2023
- HighVista Strategies 2022 Q4 filed Feb. 14, 2023
- HighVista Strategies 2022 Q3 filed Nov. 14, 2022
- HighVista Strategies 2022 Q2 filed Aug. 15, 2022
- HighVista Strategies 2022 Q1 filed May 16, 2022
- HighVista Strategies 2021 Q4 filed Feb. 14, 2022
- HighVista Strategies 2021 Q3 filed Nov. 15, 2021
- HighVista Strategies 2021 Q2 filed Aug. 16, 2021
- HighVista Strategies 2021 Q1 filed May 17, 2021
- HighVista Strategies 2020 Q4 filed Feb. 16, 2021
- HighVista Strategies 2020 Q3 filed Nov. 16, 2020
- HighVista Strategies 2020 Q2 filed Aug. 14, 2020
- HighVista Strategies 2020 Q1 filed May 15, 2020